Research Nester released a report titled “Amphetamine Drug Market – Global Demand Analysis & Opportunity Outlook 2028” which delivers a detailed overview of the amphetamine drug market in terms of market segmentation by application, demography, distribution channel, and region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis, and Porter’s five force model.
The amphetamine drug market is segmented by application, demography, distribution channel, and region. Based on the application, the amphetamine drug market is segmented into ADHD, narcolepsy, obesity, depression, and others, out of which the depression segment is anticipated to dominate the market owing to the increase in the prevalence of depression among adults and children around the world. Based on demographics, the amphetamine drug market has been bifurcated into children and adults. Among the demographic segment, the adult is anticipated to hold the largest share in the market attributed to a large adult patient population. The amphetamine drug market is anticipated to record a robust CAGR during the forecast period, i.e. 2020-2028. This market is thriving on the back of a rising number of ADHD patients and governments’ approvals and initiatives to address the health-related problems. Along with this, the investments into the healthcare system for the betterment of society further are anticipated to raise the market growth. According to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), in 2015, there were 17.2 million individuals who used stimulants, of which 1.8 million were youth and 4.9 million were adults.
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”
Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-2527
Based on the regional analysis, the amphetamine drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North American region is anticipated to dominate the global market and accounted for the rising prevalence number of depression and ADHD patients globally. Additionally, the continuous focus of key market players is on the consumers, encouraging them to innovate in the market. Such factors are anticipated to boost the market growth of the region. The market in Europe is anticipated to hold the second-largest share owing to the presence of massive pharmaceutical firms in the region
The increasing number of ADHD patients worldwide
According to the survey done by the Centers for Disease Control and Prevention (CDC), in 2016, 0.388 million children aged 2–5 years, 4 million children aged 6–11 years, and 3 million children aged 12–17 years, were diagnosed with ADHD in the U.S.
The global surge in the number of incidences is associated with ADHD due to the dearth of established treatment for this disorder. People are left with long-running medication procedures for their treatment. Medicinal treatment through CNS stimulants such as amphetamine is the most preferred way to treat the patient. This is expected to incite the growth of the global amphetamine drug market. However, the side effects and contraindications related to amphetamine drugs are some of the factors that are estimated to limit the market growth.
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”
Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-2527
This report also provides the existing competitive scenario of some of the key players of the amphetamine drug market which includes company profiling of Teva Pharmaceutical Industries Ltd. (TLV: TEVA), Pfizer Inc. (NYSE: PFE), Novartis AG (SWX: NOVN), Eli Lilly and Company (NYSE: LLY), GlaxoSmithKline plc (LON: GSK), Mallinckrodt Company (NYSE: MNK), Johnson & Johnson Services, Inc. (NYSE: JNJ), Hisamitsu Pharmaceutical Co., Inc. (TYO: 4530), and Purdue Pharma L.P. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the amphetamine drug market that will help industry consultants, manufacturers, existing players searching for expansion opportunities, new players searching possibilities, and other stakeholders to align their market-centric strategies accordingly to the ongoing and expected trends in the future.
Browse Complete Summary of this report @ https://www.researchnester.com/reports/amphetamine-drug-market/2527
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates, and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
–Related Trending Reports:-
Injectable Drugs For Type-2 Diabetes Market
Thermoelectric Module Market
Cap Liner Market
Automated Hand Sanitizer Vending Machine Market
Intercontinental Ballistic Missile Market
Medical Plastics Market
Aerosol Valves Market
Dexrazoxane Market
